Cardlytics Inc

$ 1.01

4.54%

15 Apr - close price

  • Market Cap 53,204,000 USD
  • Current Price $ 1.01
  • High / Low $ 1.02 / 0.94
  • Stock P/E N/A
  • Book Value -0.12
  • EPS -1.95
  • Next Earning Report 2026-05-06
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.09 %
  • ROE -3.26 %
  • 52 Week High 3.28
  • 52 Week Low 0.66

About

Cardlytics, Inc. operates an advertising platform within financial institutions' digital channels including online, mobile, email, and various real-time notifications in the United States and the United Kingdom. The company is headquartered in Atlanta, Georgia.

Analyst Target Price

$1.04

Quarterly Earnings

Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Reported Date 2026-03-032025-11-042025-07-282025-04-302025-03-122024-11-062024-08-072024-05-082024-03-142023-11-082023-08-012023-05-04
Reported EPS 0.03-0.07-0.13-0.21-0.31-0.15-0.15-0.090.140.01-0.24-0.25
Estimated EPS -0.2767-0.3467-0.39-0.2667-0.47-0.24-0.13-0.110.12-0.01-0.35-0.56
Surprise 0.30670.27670.260.05670.160.09-0.020.020.020.020.110.31
Surprise Percentage 110.8421%79.8096%66.6667%21.2598%34.0426%37.5%-15.3846%18.1818%16.6667%200%31.4286%55.3571%

Next Quarterly Earnings

Mar 2026
Reported Date 2026-05-06
Fiscal Date Ending 2026-03-31
Estimated EPS
Currency USD

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: CDLX

...
Cardlytics Inc stock (US14161W1053): Is its bank-tied ad data edge strong enough to unlock new upsid

2026-04-13 22:09:11

Cardlytics Inc. offers a unique investment opportunity in personalized marketing, leveraging anonymized consumer spending data from bank partners for targeted advertising campaigns. This business model positions the company at the intersection of fintech and ad tech, providing stable, recurring revenue from long-term bank contracts. For U.S. investors, Cardlytics offers exposure to the banking sector's digital transformation without direct bank stock ownership, benefiting from economic recoveries and increased transaction flows.

...
Cardlytics Inc stock (US14161W1053): Is its bank-tied ad data edge strong enough to unlock new upsid

2026-04-13 21:40:15

Cardlytics Inc. leverages anonymized consumer spending data from bank partners to deliver hyper-targeted advertising, offering a unique play on personalized marketing. This model, which embeds incentives directly into bank apps, provides stability through recurring revenue from long-term bank contracts. For U.S. and English-speaking market investors, Cardlytics presents an opportunity to invest in fintech and ad tech, with growth driven by rising mobile banking penetration, AI enhancements, and strategic partnerships.

...
Cardlytics (NASDAQ: CDLX) seeks approval for reverse stock split, director slate and executive pay

2026-04-09 20:09:59

Cardlytics (NASDAQ: CDLX) is asking shareholders to vote on a potential reverse stock split, director elections, and executive compensation at its May 20, 2026 annual meeting. The proposed reverse stock split, ranging from 1-for-5 to 1-for-15, aims to help the company meet Nasdaq's minimum bid price requirement. Shareholders will also vote on electing three Class II directors and ratifying Deloitte & Touche LLP as the 2026 auditor.

Insider sale notice — Cardlytics (NASDAQ: CDLX) files Form 144 to sell 50,000 shares

2026-04-07 20:10:47

Cardlytics Inc. (CDLX) has filed a Form 144, indicating a proposed sale of 50,000 common shares by an affiliate, reported on March 25, 2026. The filing also details restricted stock vesting events for 6,898 shares on July 1, 2024, and 13,102 shares on August 14, 2024, both related to compensation. Fidelity Brokerage Services LLC is listed as the broker for these transactions.

[Form 4] Cardlytics, Inc. Insider Trading Activity

2026-04-06 21:19:13

Cardlytics, Inc. CEO Amit Gupta reported an open-market sale of 69,833 shares of common stock at an average price of $1.187 per share. This sale was exclusively to cover tax withholding obligations from RSUs that vested on April 1, 2026. Following the transaction, Gupta still directly holds 987,387 shares of Cardlytics common stock.

...
Cardlytics (CDLX) CEO Gupta sells $82,891 in shares

2026-04-06 21:10:28

Cardlytics (CDLX) CEO Amit Gupta sold 69,833 shares of common stock for $82,891 to cover tax obligations from vested RSUs. This transaction leaves Gupta with 987,387 shares. The company recently reported mixed Q4 2025 earnings, exceeding revenue forecasts but meeting EPS expectations, and sold its Bridg platform.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi